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Stopping-power prediction with dual-energy computed tomography
A substantial component of range uncertainty in ion therapy is attributed to the
prediction of ion stopping-power ratio (SPR) from x-ray computed tomography
(CT). Besides imaging technology that uses the same particles as are employed
for treatment (e.g., proton CT), dual-energy CT (DECT) has been proposed to
potentially improve this prediction within the framework of clinical x-ray CT. The
aim of this thesis was to demonstrate improved SPR prediction with DECT from
theoretical, experimental and clinical viewpoints.
In the first step, an optimized approach was developed on the basis of a rigorous
theoretical framework. Since variability in the SPR of human tissue is dominated
by electron density, its universal and accurate determination solves the larger part
of the problem and reduces the empirical component to the stopping number,
which represents the second factor in SPR. By inferring the stopping number from
DECT-derived photon cross sections, linear mixing behavior was demonstrated,
which enabled proper calibration and the possibility to quantify uncertainty. The
optimized approach was experimentally verified and benchmarked against the
clinical gold standard in homogeneous animal tissues (human-like composition)
and an anthropomorphic head phantom (human-like geometry). Furthermore,
significant range differences to the standard approach were observed in patients,
highlighting clinical relevance.
From a methodological and experimental perspective, the developed method of
SPR prediction with DECT outperforms the clinical gold standard and reduces the
associated uncertainty to below 1 %, which might eventually lead to the reduction
of treatment margins.
The thesis is presented in cumulative format and comprises eight peer-reviewed
publications.

Reichweitenvorhersage mit der Zwei-Spektren-Computertomographie
In der Ionentherapie ist ein wesentlicher Anteil der Reichweiteunsicherheit auf die
Vorhersage des Ionenbremsvermo¨gens (SPR) mittels Ro¨ntgen-Computertomographie
(CT) zuru¨ckzufu¨hren. Anstatt die Bildgebung mit den gleichen Partikeln wie
bei der Therapie durchzufu¨hren (z.B. Protonen-CT), wurde die Zwei-Spektren-
Computertomographie (DECT) als vielversprechend angesehen, die Vorhersagege-
nauigkeit der klinischen CT-Bildgebung mit Ro¨ntgenstrahlen zu verbessern. Im
Rahmen dieser Arbeit wurde diese Hypothese durch theoretische, experimentelle
und klinische Untersuchungen u¨berpru¨ft.
Dazu wurde zuna¨chst ein optimiertes Verfahren zur SPR-Vorhersage mithilfe
von DECT entwickelt, welches auf einer fundierten theoretischen Basis beruht.
Da das Bremsvermo¨gen von menschlichen Geweben maßgeblich von der Elektro-
nendichte abha¨ngt, tra¨gt dessen universale und genaue Bestimmung bereits zur
u¨berwiegenden Problemlo¨sung bei und beschra¨nkt den Effekt der Empirie auf
die zweite Einflussgro¨ße des Bremsvermo¨gens, die Bremszahl. Leitet man die
Bremszahl aus Wechselwirkungsquerschnitten von Photonen her, stellt sich ein
lineares Mischungsverhalten ein, welches eine ordnungsgema¨ße Kalibrierung und
Unsicherheitsabscha¨tzung ermo¨glicht. Diese optimierte Vorgehensweise wurde in
homogenen tierischen Geweben (mit menschena¨hnlicher Zusammensetzung) und in
einem anthropomorphen Kopfphantom (mit menschena¨hnlicher Geometrie) experi-
mentell verifiziert und mit dem derzeitigen klinischen Standardverfahren verglichen.
Des Weiteren wurden zwischen beiden Methoden signifikante Reichweiteunter-
schiede in Patienten festgestellt, die dessen klinische Relevanz betonen.
Im Vergleich zum derzeitigen klinischen Standardverfahren konnte die eigens en-
twickelte DECT-basierte SPR-Vorhersage aus methodischer und experimenteller
Sicht u¨berzeugen und die Unsicherheiten auf unter 1 % verringern, welches schließlich
zu einer Verkleinerung von Sicherheitssa¨umen in der Patientenbehandlung fu¨hren
kann.
Die vorliegende Doktorarbeit wurde kumulativ angefertigt und umfasst acht von
Experten begutachtete Vero¨ffentlichungen.
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Chapter 1
Introduction
1.1 — Motivation
The purpose of radiation therapy is to eliminate or inactivate cancer cells by in-
ducing DNA damage with ionizing radiation. While many types and sources of
radiation are conceivable for this purpose, the majority of treatments are nowa-
days performed with a spectrum of x-ray radiation produced from MeV electrons
in a medical linear accelerator (LINAC). With modern techniques of application,
various beams of modulated intensity are directed to the target region from dif-
ferent angles to conform dose to the tumor [1]. Sparing the surrounding healthy
tissue is thereby only possible to a certain extent due to the physical nature of
x-ray dose deposition in tissue, which is maximal a few millimeters below the skin
and then decreases with depth (figure 1).
For heavy charged particles, the characteristics of dose deposition are fundamen-
tally different. Ions with therapeutic kinetic energy in the order of 100 MeV per
nucleon slow down via electronic collisions, densely ionizing the medium along
their path until they finally stop after a certain range. Most of the energy is
thereby transferred at the end of their path, forming the so-called Bragg peak.
With low dose deposition entering the tissue and a sudden increase at the end of
range, the depth-dose curve of ions is ‘inverted’ compared to the photon profile
(figure 1). This potentially allows for better concentration of dose to the tu-
mor and more effective sparing of healthy tissue, in particular behind the target.
Therefore, protons and heavier ions have been suggested early on as promising
particle candidates for radiation therapy [2].
However, due to the steep gradient at the distal fall-off of the Bragg peak, the
delivered dose distribution is susceptible to uncertainty in treatment planning
and delivery [5, 6]. Important sources of uncertainty are
• pre-treatment patient imaging, the role of which is (a) to locate anatom-
ical structures such as the target and organs-at-risk; and (b) to serve as
a quantitative basis for dose calculation (clinical gold standard: computed
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Figure 1: Normalized depth-dose curves of 6 MV photons and 110 MeV
protons in water from radiation transport simulations with the FLUKA Monte
Carlo code [3, 4].
tomography (CT) — see section 2.3),
• day-to-day variations in patient setup, beam delivery or patient anatomy
(e.g., filling of cavities),
• changes in anatomy on a longer time scale (e.g., tumor shrinkage, patient
weight loss),
• and organ motion during irradiation.
Different techniques are currently being used or developed for the mitigation of
range uncertainty, such as motion management [7,8], robust optimization [9,10],
or image-guided radiotherapy [11,12] The remaining uncertainty is accounted for
in clinical routine by adding safety margins to the delineated target volume to
make sure the tumor is fully covered in any reasonably probable scenario [13].
Typical range margins are composed of an absolute component of 1-3 mm and
a relative component of 2.5-3.5 % (figure 2), leading to a considerably increased
irradiation of healthy tissue.
Furthermore, range uncertainty is challenging to quantify (as reflected in the
variety of margin recipes), so that compromises in beam configuration are often
being made for safety reasons. For example, it is avoided to direct a beam frontally
at an organ-at-risk [6]. Since this usually leads to a suboptimal dose distribution,
the quantification and ideally reduction of range uncertainty is essential to profit
from the dosimetric advantage of ion therapy.
From figure 2, it is evident that the treatment of a tumor that is not seated in the
first few centimeters below the skin would profit particularly from a reduction of
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Figure 2: Typical range margin recipes used in different proton therapy
centers: MD Anderson Proton Therapy Center, Houston and Loma Linda
University Medical Center (3 mm + 3.5 %); MGH Proton Beam Therapy
Center, Boston (1 mm + 3.5 %); and UF Health Proton Therapy Institute,
Jacksonville (1.5 mm + 2.5 %) [5]. Dotted lines indicate how the respective
margins would change if the relative uncertainty component was limited to 1 %.
the relative component of range uncertainty (i.e., the slope). This component is
dominated by the prediction of ion stopping-power ratio (SPR) on the basis of
the planning CT image (section 2.3). Due to conversion between the interaction
mechanisms of different particle types (x-ray photons for imaging and ions for
treatment), this prediction is affected by substantial uncertainty of about 1-3 %
[5,14–17].
The conversion problem promises to be solved if the same particles were used
for both imaging and treatment. This would naturally be the case for proton or
heavier ion CT [18,19]. However, the according technology is still in development
phase [20] and it is not clear whether a clinical system with suitable characteristics
will be available any time soon.
Nevertheless, advancement in SPR prediction might already be possible within
the framework of clinical x-ray CT. In 2006, the first commercial dual-energy
computed tomography (DECT) scanner was launched to market [21]. Scanning
the patient with two separated x-ray energy spectra grants access to the under-
lying radiological tissue parameters, such as electron density and photon cross
section or effective atomic number [22–24]. These parameters have been used for
SPR prediction with DECT [25–27]. Thereby, the impact of the empirical com-
ponent of SPR prediction is strongly mitigated, which in return should reduce
the associated CT-related component of range uncertainty in ion therapy.
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1.2 — Aim of this thesis
Many methods are available today to determine material properties such as elec-
tron density or effective atomic number from DECT data [22–24,26–34]. Either,
they were already published shortly after the invention of computed tomography,
or they were triggered by the clinical introduction of DECT in recent years. Before
the start of this dissertation project, it was not clear, which of the many published
methods would be best suited and how to optimally exploit the determined tissue
parameters for SPR prediction.
Furthermore, experimental results on the hypothesized superiority of DECT-
based SPR prediction methods had been inconclusive, especially with regard to
their transferability to complex human morphology and tissue composition. This
is partly owing to the fact that methods for direct verification of ion stopping
power or range in patients are currently not accurate enough to serve as a reli-
able reference. Finally, it also remained unclear how a potential advantage would
translate into clinical application.
Therefore, the aim of this thesis was to clarify whether SPR prediction can be
improved using clinical DECT, thus potentially limiting CT-related range uncer-
tainty to 1 % (figure 2). The steps taken towards achieving this aim were
• methodological development of a rigorous mathematical and physical
framework for the prediction of SPR with DECT and the translation of its
results into the implementation of an optimized approach,
• experimental verification of the refined approach using established vali-
dated references and its benchmark against the clinical gold standard,
• and finally assessment of its clinical relevance.
After description of the background (chapter 2), an overview of the main results of
the publications included in this thesis is presented (chapter 3) and the original
manuscripts are provided (chapter 4), followed by a comprehensive discussion
(chapter 5) and summary (chapter 6).
Chapter 2
Background
2.1 — Stopping power of ions in matter
The stopping power of ions in matter is defined as the mean energy loss per unit
path length, S = −dE/dx. The stopping power due to electronic collisions is
given by the Bethe formula [35]
S = k0 n
z2
β2
L(β) , (2.1)
where n is the electron density of the medium, z and β are the charge and rel-
ativistic velocity of the projectile, L is the so-called stopping number and k0 is
composed of natural constants taking the value
k0 = 4pi(h¯cα)
2/(mec
2) = 5.1× 10−25 MeVcm2 . (2.2)
In the energy regime relevant to ion therapy, it is admissible to write the stopping
number in an approximated form (figure 3, appendix A1),
L ≈ L(β, I) ≈ ln
(
2mec
2β2
1− β2
)
− β2 − ln I , (2.3)
where the only remaining dependencies are the velocity, β, and the mean excita-
tion energy or ‘I-value’, I (appendix A2).
It is a useful convention in radiotherapy treatment planning to normalize a quan-
tity, x, to its respective value for water, xw, to obtain a dimensionless quantity xˆ.
From this point on, we usually refer to quantities such as electron density or stop-
ping number in this way. The suffix ‘relative to water’ is hereby mostly omitted
to increase readability, as it can be easily inferred from context. An exception to
this guideline is the stopping power relative to water, which will be referred to in
this thesis by convention as the stopping-power ratio (SPR).
6 Chapter 2: Background
10 1 100 101 102 103
kinetic energy (MeV/u)
101
102
103
st
op
p
in
g 
p
o
w
er
 (
M
eV
/c
m
)
NIST PSTAR
uncorrected Bethe
10 1
101
re
si
d
u
a
l 
ra
n
ge
 (
cm
)
residual range
Figure 3: Stopping power and residual range of protons in water. The
stopping power was obtained from the PSTAR database of the National
Institute of Standards and Technology (NIST) [36] (solid line) and from an
independent calculation using the uncorrected Bethe formula (equations 2.1
and 2.3, dashed line). The deviations at high (low) energy are mainly due
to the density (shell) effect, well out of the energy window relevant to ion
therapy (appendix A1).
Taking this ratio in the Bethe formula 2.1, all prefactors, and in particular the
dependency on z2/β2, cancel out and SPR reduces to a simple product of electron
density and stopping number (cf., section 2.1.2 in pub. Ib), that is
Ŝ = n̂L̂ . (2.4)
With the approximation of equation 2.3, the relative stopping number,
L̂ =
L(β, I)
L(β, Iw)
=
ln 2mec
2β2
1−β2 − β2 − ln I
ln 2mec
2β2
1−β2 − β2 − ln Iw
(2.5)
shows only a minor dependence on β, and thus the kinetic beam energy [Ib, fig-
ure 1]. Consequently, even the last projectile-related dependence in equation 2.4
is practically removed. In this respect, SPR can be viewed as a pure material
quantity, depending only on electron density and stopping number or I-value of
the material traversed.
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Figure 4: Energy dependence of the mass attenuation coefficient (µ/ρ) of
photons in water (left) and hydroxyapatite (right). In contrast to Compton
scattering, the photoelectric effect features a strong dependence on energy (x-
axis) and material composition (difference between water and hydroxyapatite).
Data taken from NIST XCOM Photon Cross Section Database [38].
2.2 — Photon absorption and (dual-energy) computed
tomography
The photon attenuation coefficient, µ, depends on electron density and elec-
tronic cross section (cf., section 2.A in pub. Ia and section 2.1.1 in pub. Ib)
such that
µ̂ = n̂σ̂ . (2.6)
The cross section is usually expressed as a sum of different interaction mecha-
nisms [37] (cf., appendix A in pub. Ia). In the relevant energy regime of x-ray
photons used in medical imaging (30-150 keV), photon attenuation is dominated
by the photoelectric effect and (incoherent) Compton scattering (figure 4). The
Compton cross section is nearly flat in energy between 30 and 150 keV and more
importantly, virtually independent of material composition. The photoelectric
cross section, on the other hand, shows a strong dependence on both photon
energy, E, and atomic number of the attenuating material, Z, and is roughly
proportional to Z3/E3.
Computed tomography (CT) displays the spatial distribution of photon attenua-
tion coefficients in the imaged object. For convenience, these are linearly trans-
formed to obtain the CT number in Hounsfield units (HU),
ξ = (µ̂− 1) · 1000 HU . (2.7)
In the original publication presenting computed tomography [39], Hounsfield al-
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ready suggested the use of two different tube voltages to distinguish materials of
high atomic number. Shortly after, specific algorithms for material decomposition
in terms of a photoelectric and Compton component [22,40,41], or electron den-
sity and effective atomic number [23,24] were suggested. However, it was not until
30 years later that the first dedicated DECT scanner was brought to market [21].
The introduced ‘dual-source’ system contains two pairs of an x-ray tube and cor-
responding detector mounted at an angle of approximately 90 degrees. The CT
scanner is therefore capable of an increased scanning speed, which is particularly
useful for time-resolved cardiac imaging [21, 42, 43]. The possibility of operating
the two tubes at different voltages thus allowing for spectral applications came
as an additional feature. Meanwhile several technical implementations of clinical
DECT exist [44,45].
2.3 — State-of-the-art stopping-power prediction
2.3.1 Basic principle
The current state-of-the-art imaging modality for treatment planning is x-ray
computed tomography due to its high geometrical fidelity (for delineation and
treatment planning) and the dependence of the CT number on electron density
(for dose calculation). In order to use the CT image for the latter purpose in
ion therapy, it has to be transformed to a 3D map of SPR. CT number and SPR
show a strong overall correlation for human tissue due to
i the mutual linear dependence on electron density;
ii correlation between some of the involved radiological parameters (e.g., elec-
tron density and atomic number);
iii correlation in elemental composition (humans mainly consist of water, lipid
and protein).
Therefore, a fully heuristic one-to-one calibration curve for the voxelwise conver-
sion of CT number to SPR is a practicable solution.
2.3.2 Calibration
Usually a calibration curve is implemented and calibrated in clinical practice as a
piece-wise linear function, often referred to as Hounsfield look-up table (HLUT).
Two basic recipes are widespread for the calibration procedure of a HLUT, namely
the ‘empirical’ [46] and the ‘stoichiometric’ [47] method.
In both methods, a set of tissue surrogates is scanned employing the same CT
acquisition and reconstruction parameters that are used for treatment planning.
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In the ‘empirical’ method, pairs of CT number and reference SPR (calculated or
measured) are then directly interpolated or fitted to obtain a calibration curve.
The stoichiometric method contains an intermediate step to account for the fact
that tissue surrogates might not be exactly tissue equivalent. Here, the tissue
surrogates are first used to fit a CT number model, which then allows for the
calculation of ‘virtual’ CT numbers of tabulated human tissues [48].
The reader is kindly referred to figure 2 in publication IIa and figure 2 in publi-
cation IIIa for two examples of a calibrated HLUT.
2.3.3 Limitations
The CT-number-to-SPR conversion is inherently ambiguous, since different phys-
ical interaction mechanisms are connected: x-ray photons for imaging; ions for
treatment. Its empirical nature thus implicates certain limitations of the HLUT
approach:
• The calibration is not unique: two materials can have the same CT number,
but different SPR and vice versa.
• The definition of a specific calibration curve contains an element of arbi-
trariness. Their is no consensus about how many line segments should be
used or whether water should be included as calibration material.
• An HLUT is static and not patient-specific, ignoring natural variability
in tissue composition within one patient or between patients of, for example,
different sex, age or pathology [48].
• Implants and other non-tissue materials are generally not represented
by a HLUT and can hence generate errors in the dose distribution [IIIa,
figure 2].

Chapter 3
Overview of results
The major results of the publications included in this thesis are summarized,
structured according to the three steps defined in section 1.2. The original
manuscripts are provided in chapter 4.
3.1 — Methodological development (Ia-c)
A major aim of this thesis was to develop an optimized approach for accurate
SPR prediction with DECT on the basis of a rigorous physical and mathematical
framework.
The baseline of the established approach is the reduced version of the Bethe for-
mula as a simple product of electron density and stopping number (equation 2.4).
The variability in SPR is dominated by the variability in electron density since
the stopping number is contained in an interval of about 0.96 for bone to 1.02 for
adipose [Ib, section 2.2]. In publication Ia, we demonstrated that the intrinsic
methodological uncertainty for electron-density determination via a simple one-
parametric linear-blending formula is below 0.2%, independently of the spectral
combination or DECT technology. Furthermore, we proposed a simple way of
calibration and quantified its uncertainty.
In addition, it was realized that the evaluated formula is mathematically equiva-
lent to the corresponding one derived by Brooks [24]. This equivalence is in fact
not immediately evident. The same holds true for Brooks’ derivation of the effec-
tive atomic number. The mathematical equivalence of the algorithms described
in references [24,26,28,30,31,34] was therefore demonstrated in a second publica-
tion [Ic]. Furthermore, while a coherent definition of the effective atomic number
was already included in appendix A.2 of publication Ia, the strong interlink be-
tween electron density and effective atomic number determination is highlighted
in clarity in publication Ic.
The determination of the second factor entering SPR prediction, that is, the stop-
ping number or equivalently the I-value, is less straightforward as it has no direct
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analogue in photon absorption and thus requires an empirical proxy. Methods
relying on the effective atomic number, as often used in previous publications on
the topic [25–27], lack a coherent treatment of tissue mixtures, which is an essen-
tial feature in patient CT images due to finite voxel size. In publication Ib, we
demonstrated how a convenient linear mixing behavior arises when using the pho-
ton attenuation cross section instead of the effective atomic number as a proxy.
The publication includes a detailed mathematical derivation as well as a discus-
sion of conceptual and practical advantages of the proposed approach.
3.2 — Experimental verification (IIa-c)
Extensive experimental verification of the developed DECT method was per-
formed in two complementary environments, each focusing on one of the two
relevant aspects of complexity influencing SPR prediction accuracy in a patient:
tissue composition (in publication IIa) and geometric morphology (in publica-
tion IIb).
Since there is still a remaining, yet small, empirical influence in DECT-based SPR
prediction in form of the stopping-number look-up table [Ib], experimental veri-
fication in biological tissue is crucial. For this, a hybrid experimental setup and
workflow for combined DECT and ion-range mesurement based on a dedicated
3D-printed sample container was developed and continuously optimized through-
out various student projects supervised by the author [49–52]. Using this setup,
several homogeneous animal tissues could be measured with an SPR accuracy of
below 0.1% and compared to DECT and SECT predictions. The mean absolute
prediction error was 0.2 % for DECT as compared to 1.5 % for SECT.
In the second and complementary project, an anthropomorphic head phantom
was used to demonstrate the accuracy of DECT-based SPR prediction in a more
realistic human morphology. Great care was taken to establish a proper virtual
SPR ground truth for this phantom by reassigning SPR measured in separate
homogeneous slabs to delineated material segmentations in a high-resolution CT
scan of the phantom. This reference SPR map was also independently validated
by comparing proton transmission measurements to Monte Carlo transport sim-
ulations based on the reference SPR map. In large homogeneous volumes of the
phantom (brain, soft tissue, trabecular bone), DECT showed a median deviation
to the reference below 1 % and thereby clearly outperformed SECT. In smaller
volumes (cortical bone, sinus cavity) and at material edges, the comparison was
inconclusive due to smoothing effects.
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3.3 — Clinical relevance (IIIa-b)
Preceding the potential clinical implementation of the established approach for
SPR prediction with DECT in ion treatment planning, it was tested on patient
data. For this, a step-wise implementation was considered to gather initial clini-
cal experience and DECT data for further investigation. In 2015 (2016), DECT
was clinically implemented in proton (and photon) therapy by our collaboration
partners at OncoRay – National Center for Radiation Research in Oncology,
Dresden. As a conservative first step of clinical implementation, a look-up table
is still applied, but to a pseudo-monoenergetic image derived from DECT (pub-
lication IIIa). In addition to potential advantages for diagnostic purposes and
contouring due to the additional information in DECT images, a rapidly growing
database of DECT images from more than 1400 patients as of November 2017 is
available for research purposes.
This database could be used to compare the DECT-based SPR prediction with
the current clinically used HLUT. Significant range differences of 1-4 mm (1-2 %)
were found in 25 head and 25 prostate tumor patients, which are considered
clinically relevant (publication IIIb).

Chapter 4
Publications
This thesis is presented in ‘cumulative’ format in accordance with the regula-
tions of the Department of Physics and Astronomy of Heidelberg University. It
comprises eight articles published in or submitted to internationally recognized
peer-reviewed journals. The individual manuscripts are referred to within this
thesis by roman numerals. Four manuscripts have been published (Ia, Ib, IIc,
IIIa), two are accepted and ‘in press’ (IIb, IIIb) and another two are currently
under review (Ic, IIa).
The dissertation is part of the joint funding project ‘Translation of dual-energy
CT into application in particle therapy’ within the National Center for Radiation
Research in Oncology (NCRO). All work was performed in close collaboration
with Patrick Wohlfahrt and Dr. Christian Richter from OncoRay – National
Center for Radiation Research in Oncology, Dresden. The focus in Heidelberg was
methodological and experimental development, while the clinical implementation
and analysis of patient data was mainly performed in Dresden.
Accordingly, the author of this thesis is first author of publications Ia–IIa, shared
first author of publication IIb and second author of publications IIc–IIIb. The
specific authors’ contributions to each article are stated in the respective following
sections.
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performed data analysis. PW and CR supported integration of the study into the
overall project strategy. CM drafted the manuscript with support from TR and
critical review by SG, PW and CR.
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# both authors share first authorship
** both authors share last authorship
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Authors’ contributions: All authors planned and conducted the proton-beam
experiments. CR was in charge of overall coordination of the measurement cam-
paign. PW performed the acquisition and processing of CT data. PW and CM
analyzed the experimental data and prepared the results. SG designed, executed
and evaluated the MC simulations. All authors discussed the results and shared
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IIIb Dual-energy CT-based proton range prediction in patients 111
IIIb — Dual-energy CT based proton range prediction
in head and pelvic tumor patients
Authors: Patrick Wohlfahrt, Christian Mo¨hler, Kristin Stu¨tzer, Steffen Greilich,
Christian Richter
Publication status (11/2017): In press, corrected proof
Journal reference: Radiotherapy and Oncology, 2017
DOI: 10.1016/j.radonc.2017.09.042
Copyright notice: The original manuscript has been removed from this online
version of the dissertation.
Authors’ contributions: PW designed the study with support from CR and
performed the evaluation of patient data. CM contributed to the implementa-
tion of the investigated approach. KS and PW conceptualized and supervised
implementation of the employed raytracing algorithm. All authors intensively
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Chapter 5
Discussion
5.1 — Methodological development
5.1.1 Distinctive features
Aiming at optimal accuracy and clinical applicability, the established approach
for DECT-based SPR prediction
A. is based on reconstructed images rather than projections,
B. factorizes into electron density and stopping number,
C. uses linear blending for electron density,
D. and uses cross section as a proxy for stopping number.
The individual features are discussed in the following subsections.
A. The algorithm is based on reconstructed images rather than projec-
tions
The determination of electron density and effective atomic number or, more gen-
erally, any processing of DECT data can be performed either in the projection
or image domain, that is, during or after image reconstruction. Shortly after
the invention of computed tomography, both the projection- and image-based al-
gorithms were already prototyped by Alvarez & Macovski [22] and Brooks [24],
respectively.
Algorithms operating on projection data allow to interact with image reconstruc-
tion and thereby, in principle, offer potential to reduce artifacts and noise. How-
ever, they might in turn require more assumptions and in particular a more spe-
cific parameterization of the photon attenuation cross section. Also, they might
not be as easily calibrated [53]. But most importantly, projection-based algo-
rithms require congruent beam projections and simultaneous acquisition of the
projections for both spectra. This is not the case for many current clinical CT
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scanners with dual energy (DE) functionality. Considering the goal of current
clinical applicability, only image-based algorithms were included in the analysis
[Ia-Ic].
Nevertheless, projection-based methods might become more interesting in the
future with the advent of photon-counting CT detectors (see section 5.3.3). In
these systems, only one x-ray tube is used while spectral separation is performed in
the detector. The projections are thus always congruent in space and time.
B. Factorization into electron density and stopping number
DECT-based SPR prediction should be divided into the determination of electron
density and stopping number for the following reasons:
• Both photons and ions, carrying an energy relevant to the discussed medical
application, interact primarily with atomic electrons in the target. Conse-
quently, electron density plays a fundamental role in both ion energy loss
(SPR) and photon attenuation (CT number) and enters linearly in the ac-
cording equations 2.4 and 2.6. Electron-density determination thus repre-
sents a ‘natural’ intermediate step in SPR prediction.
• We demonstrated that the determination of electron density from DECT
data is simple, robust and has virtually negligible methodological uncer-
tainty [Ia].
• Electron density dominates the variability in SPR of human tissue to about
95 % [Ib, section 2.2]. By its robust and accurate determination (see previous
item), the largest part of the problem is already solved.
• By factorizing into electron density and stopping number, the empirical
component (stopping number) is clearly isolated such that its impact on the
overall uncertainty can be mitigated [Ib].
• Even if it is not explicitly calculated as part of an algorithm, electron-density
information is always implicitly encoded simply due to the physics (see first
item). For example, Taasti et al. [54] proposed a 2D empirical parameteriza-
tion in dependence of the high- and low-energy CT numbers. However, the
parameterization contains the exact term of linear blending that represents
electron density [Ia]. As the primary advantage of their parameterization,
Taasti et al. claim to reduce the number of required steps in the conversion
from two to one. While this may be a correct observation from the method-
ological (or philosophical) point of view, it has no practical impact, as the
equations for the two steps can equally be joined into one arithmetically.
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C. Use linear blending for electron density
The rationale to use a simple linear-blending formula [Ia, equation 3] for DECT-
based electron-density determination is elaborated in publication Ia from many
different perspectives. The main line of argument is that with a methodological
uncertainty of below 0.2 %, this method is already more than sufficiently accu-
rate so that further complexity in the method is only counterproductive. More
conceptual justifications for the linear-blending equation are [Ia, appendix]
i that it represents the only solution for electron density that is valid for any
compound and not just single chemical elements and
ii that it follows as a mathematical implication from any definition of a single
effective atomic number
D. Use cross section as a proxy for stopping number
Yang et al. [25] proposed an empirical relationship between the effective atomic
number and the logarithm of the I-value, which can then be inserted into the
Bethe formula (equation 2.5) to obtain stopping number and eventually SPR.
From equations 2.4 and 2.6, it becomes clear that a more direct and intuitive way
is to link the stopping number (instead of ln(I)) to the cross section (instead of
effective atomic number).
In terms of image contrast, cross section and effective atomic number contain the
same image information. Using an analogue from the field of image processing, the
transformation between the two quantities can be viewed as a ‘gamma correction’
combined with a constant offset (cf., equation B7 in pub. Ib or equation 2 in
pub. Ic). However, the use of cross sections ensures linear mixing and thus
enables proper calibration (section 5.1.2) and quantification of uncertainty in the
convex hull, as discussed in detail in publication Ib. The linear mixing property
is conserved under any affine variable transformation such that a power of the
effective atomic number, Zmeff with m ≈ 3, might be used equivalently as a proxy
for the stopping number.
5.1.2 Details of calibration
Choice of the cross section: To illustrate the general properties of the method,
the lower-energy cross section, σ̂l, was initially chosen arbitrarily. In section 2.5
of publication Ib, it was already noted that any linear combination of σ̂l and σ̂h
could be used preserving the linear mixing properties and all associated advan-
tages. Such a linear combination corresponds to a pseudo-monoenergetic cross
section. In the most recent publication, a monoenergetic cross section at 60 keV is
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used [IIa]. One advantage of this is that the look-up table is completely indepen-
dent of the CT scanner and protocol. A specific calibration of the cross section
as described in section 2.4 of publication IIa is therefore obsolete. Furthermore,
existing clinical software for DECT-based calculation of pseudo-monoenergetic
images could be integrated into the workflow (see figure 3 in pub. IIa).
Choice of ion kinetic energy: A kinetic energy of 200 MeV/u was initially cho-
sen [Ib] to calculate L̂ with equation 2.5, again with no consequence for the general
conclusions derived. For application in patients, an effective energy of 100 MeV/u
is recommended to minimize systematic bias due to the small energy dependence
in SPR [55].
Shape of calibration curve: A very simple calibration line was originally defined
to easily demonstrate the general mechanism of quantifying uncertainty in the
convex hull. The calibration curve was later refined to better fit the most abun-
dant human tissues in order to avoid systematic bias. The use of a piece-wise
linear function conveniently suits the purpose and underlines the analogy to a
HLUT (cf., figure 2 in pub. IIa).
Look-up table: A specific look-up table is provided in publication IIa (Table S3).
Six reference human tissues or molecular base components from reference [48] are
used as data points in the calibration. The selection of these is easier and less
arbitrary than in the case of a HLUT, as their variance is reduced by definition
(variance due to density is already removed).
Comment on the use of average bone tissues from White et al., 1987 [56]: For
the calibration of a look-up table using human reference tissues, it is important
to notice that the table for the elemental composition of human bones in White
et al., 1987 [56, table V] lists large-scale volumetric averages (e.g., ‘femur - spher-
ical head’, ‘humerus - cylindrical shaft’, see appendix A3). The tabulated data
were accordingly intended for use in the manufacturing of radiological phantoms.
However, they are of limited use for an analysis on smaller spatial scale (e.g., CT
voxel). For the calibration of a look-up table, it is therefore crucial to include
the base constituents of bones as documented in Woodard and White, 1986 [48],
rather than the average bones. For example, trabecular bone is quite abundant
in the pelvic region [IIIb] and should thus be considered in the calibration. Nev-
ertheless, the average bones can be used to visualize the linear mixing behavior
in the L̂ (σ̂)-plane as was done, for example, in figure 2 of publication IIa. These
considerations apply in the same way to any definition of a look-up table, in
particular the stoichiometric calibration.
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Figure 5: Schematic visualization of the overall strategy of experimental
verification. One experiment was performed in each ‘complexity dimension’:
animal tissues for composition [IIa] and the anthropomorphic head phantom
for geometry [IIb]. Compared to a simple experiment using homogeneous
tissue surrogates [26, 27], the ‘extrapolation uncertainty’ (visualized by the
dashed lines) is reduced.
5.2 — Experimental verification
5.2.1 Overall strategy
Before the start of the NCRO project, experimental verification of DECT-based
SPR prediction methods had been performed almost exclusively in homogeneous
tissue surrogates, usually in the form of cylindrical inserts in a simple non-
anthropomorphic phantom. Mean absolute deviations of DECT predictions in
the order of 0.5 % had been observed [26, 27]. While an experiment of this type
can serve as first test of a new method, the results should not be transferred to a
patient case, due to the following main limitations:
i Composition: Tissue-surrogates are only approximately tissue equivalent, in
particular for ion interaction, which is often not explicitly modeled. Since
DECT-based SPR prediction still involves an empirical component, it should
be tested in materials as similar to human tissue as possible. In an extreme
case, a study that is purely based on non-tissue material can even lead to
false conclusions, as demonstrated in publication IIc.
ii Geometry: Typical validation or calibration phantoms are also strongly sim-
plified in geometry for practical reasons, ignoring heterogeneity, material
transitions and all kinds of anisotropy.
In order to better approximate realistic composition and geometry, the pursued
verification strategy was therefore to perform two experiments [IIa, IIb], in which
one parameter each was kept simple, while the other was made as realistic as
possible. The combined results are then projected to the patient case with reduced
‘extrapolation uncertainty’ (figure 5).
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5.2.2 Experimental uncertainty of SPR reference
The goal of the experiments was to allow evaluation of absolute SPR prediction
at an uncertainty level of below 1 % (cf., section 1.2) and thus to enable discrim-
ination between the performance of different methods, in particular DECT vs.
SECT. Therefore, a major part of the experimental development was dedicated
to minimizing experimental uncertainty. For the anthropomorphic head phan-
tom, a full virtual 3D reference map was established with a validated uncertainty
in SPR and range within 0.3 % and 1 mm, respectively [IIb].
The experimental setup described and used in publication IIa for the measure-
ment of animal tissues, was developed and optimized in the course of four student
projects [49–52]. Compared to previous experiments of similar type [15, 57, 58],
a substantial increase in accuracy was achieved by design of the 3D-printed sam-
ple container, which is carefully adapted to match the specific requirements of
both the DECT scanner and the ion beam line [IIa, figure 1]. The uncertainty
component due to sample thickness is thus eliminated, which reduces experimen-
tal uncertainty for a homogeneous substance (ideally liquid) to below 0.1 %. At
this uncertainty level, the developed experimental setup can also be used for the
determination of I-values (section 5.4.2).
5.2.3 Accuracy of SPR prediction
In both experimental settings, DECT showed considerably superior accuracy in
SPR prediction compared to the standard HLUT-based approach (see summary of
results in section 3). According to the overall strategy of experimental verification
(figure 5), a similar advantage of DECT in SPR accuracy can thus be expected
in clinical setting.
5.3 — Clinical relevance
5.3.1 Impact on range uncertainty
The impact of SPR uncertainty on dose or ion-range uncertainty is rather non-
trivial and case-dependent. For the evaluated example treatment plan in the
head phantom, significant difference in ion ranges were not observed between the
different evaluated methods, despite considerable differences in the performance
on voxel-wise SPR level. This is due to a partly dominating, additional effect that
was observed at material transitions, which lead to compensation of systematic
SPR prediction error in some cases [IIb, figure 5].
On the other hand, the relative comparison in a patient cohort showed signifi-
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cant range differences of clinical relevance between the DECT- and HLUT-based
methods [IIIb]. Here, data suggests that a systematic mean (or median) SPR bias
in the irradiated volume translates into a mean (or median) range bias of roughly
the same magnitude [IIIb, figure 4], which can be also intuitively expected. This
indicates that a net advantage in SPR prediction might directly translate into an
net advantage in range prediction.
5.3.2 Practical considerations for clinical implementation
For the publications IIa, IIb and IIIb, a mix of existing clinical software (mainly
Siemens syngo.CT DE Rho/Z and Monoenergetic Plus) and self-written Python
scripts was used. The specific implementations are described in the respective
papers (e.g., figure 3 in pub. IIa). For the clinical use outside a defined research
environment, however, it will be necessary to implement the full chain in certified
medical products. This could be done either in the post-processing software that
is provided with CT scanners or inside the treatment planning system (TPS).
The following scenarios are therefore possible:
A complete implementation in CT software (interface SPR)
B complete implementation in TPS (interface CT number)
C shared implementation (interface, e.g., electron density/cross section)
Version A might be preferable to decrease image noise and artifacts in the final
SPR image. Algorithms for this purpose are already implemented, for example,
in the above-mentioned clinical software applications and they could be directly
transferred to the calculation of SPR.
5.3.3 Future technological development
Currently, a new generation of CT detectors is being developed. Replacing the
rather slow scintillating crystal of conventional energy-integrating detectors by a
semi-conductor with fast read-out electronics, the registration of single photons
is possible [59]. By setting different thresholds on the signal, incoming photons
can be sorted into multiple energy bins, enabling spectral applications [60].
One advantage of the so-called photon-counting CT is the automatic availability
of spectral information with every scan without specific settings so that multi-
energy functionality can naturally find broader application. Furthermore, the
system could remove certain limitations of current DECT technology, such as the
small field of view of current dual-source systems or the time offset between the
two projections in the sequential scanning technique.
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5.4 — Additional applications of dual-energy CT in ra-
diation therapy
Alongside the main focus of this thesis, as reflected in the publications, further
potential applications of DECT in radiation therapy were investigated, mainly in
associated student projects supervised by the author [49–52,61].
5.4.1 Dual-energy CT for non-tissue material
The benefit of DECT can be particularly large in the presence of non-tissue mate-
rials such as implants or contrast agent, which are generally not well represented
by a HLUT (section 2.3.3). The applications, described in the next two para-
graphs, are expected to be of potential relevance for conventional photon therapy
in addition to ion therapy. For dose calculation in photon therapy, the quantity
of interest is electron density instead of SPR.
Identification and quantification of implants
Many radiotherapy patients have implants, which usually need to be contoured
and overridden in the CT image during treatment planning. A practical prob-
lem is the often unknown composition of the implant, which makes the correct
assignment of electron density and SPR difficult1. DECT could help in both char-
acterizing the implant and calculate a more accurate electron density and SPR
(within potential limitation at higher atomic numbers [Ia] or due to the remaining
empirical component [Ib]). The extra step of contouring might even become ob-
solete. First experiments with PALACOS R© bone cement (Heraeus Medical) and
interbody fusion cages (type ‘Harms’) are documented in a master’s thesis [61].
The results underline the potential of DECT to better quantify electron density
and SPR of the investigated materials.
Dose calculation on DECT scans with iodinated contrast agent
An iodinated contrast agent is commonly used in pre-treatment imaging to sup-
port tumor diagnostics and delineation. A second ‘native’ CT scan (i.e., without
contrast medium), is then required for dose calculation, as the large atomic num-
ber of iodine hampers CT conversion via an HLUT. On the other hand, electron
density should remain almost unaffected by the contrast agent due to its low con-
centration in tissue. An electron-density image derived from contrast-enhanced
DECT should therefore resemble a native electron-density image. Dose calcula-
tion based on a DECT scan with contrast agent is therefore conceivable. The
1Personal communication, B. Ackermann, Heidelberg Ion Beam Therapy Center (HIT)
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additional native scan would become obsolete, leading to a simplified workflow
and a reduction of the patient dose by half.
The remaining impact of contrast agent on DECT-derived electron-density and
SPR images was studied in a dilution series of Imeron R© 300 (Bracco Imag-
ing Deutschland GmbH, Germany) over a range of typical iodine concentra-
tions [61]. The impact on both electron density and SPR could be limited to 1 %
instead of 5-10 % when using contrast-enhanced single-energy computed tomog-
raphy (SECT).
A clinical trial is currently underway at DKFZ to investigate patient treatment
planning based on contrast-enhanced DECT.
5.4.2 Measurement of I-values
The developed experimental setup [IIa] can be used for the measurement of I-
values. For this application, DECT serves as an efficient tool to eliminate elec-
tron density (equation 2.4). Due to the logarithmic dependence of the stopping
number on the I-value (equation 2.3), the achieved reduction of uncertainty in
the measurement of both SPR and electron density is essential here. Besides,
the setup was optimized for high sample throughput, for example, by using a
remote-controlled linear table. With a rate of below two minutes per sample, it is
possible to acquire sufficient statistics to quantify uncertainty or variability.
In this way, the method was applied in one of the above-mentioned projects
to determine elemental I-values by multivariate regression to measurements of
aqueous solutions [51]. The I-value of phosphorus was found to be significantly
lower than the literature value, which would have an impact on any calibrated
SPR prediction for bone.
Further experiments of the described type can be performed in the future, for
example, to investigate natural I-value variability in tissue or to determine the
I-value of water, which is of immediate relevance to ion therapy and still subject
to considerable uncertainty [62,63].

Chapter 6
Summary
An optimized approach for stopping-power ratio (SPR) prediction with clinical
dual-energy computed tomography (DECT) was established, experimentally val-
idated and clinically tested.
The refinement of algorithms based on reconstructed images rather than
projections allowed for immediate application using common DECT technology,
where the high- and low-energy projections are often not congruent in space or
time. The ‘natural’ decomposition into separate determination of electron den-
sity and stopping number (i.e., the two basic dependencies in SPR) minimized the
impact of the empirical component. This in turn maximizes the methodological
benefits of using DECT compared to SECT, since the limitations of a SECT-
based HLUT approach (ambiguous, static, not patient specific) can be ascribed
mainly to its empirical nature.
In the first step of the developed approach, electron density was obtained from
DECT data by a simple one-parametric linear-blending formula. The method-
ological uncertainty was shown to be below 0.2 % for arbitrary mixtures of human
tissue and for any calibrated DECT system. A simple method for the calibration
of the linear-blending parameter was proposed. The approach was also concep-
tually justified as the only universal solution that is valid for both pure elements
and chemical compounds.
To obtain the stopping number in the second step, we proposed to use the photon
absorption cross section obtained from DECT as an empirical proxy rather than
the effective atomic number. This ensures, among other advantages, a proper
treatment of mixtures, which are crucial in CT imaging on all scales from mi-
croscopic to voxel level. This linear mixing property enables simple and effective
calibration using a piecewise linear function in analogy to an HLUT. Furthermore,
an upper limit of uncertainty of 0.6 % was determined for arbitrary mixtures of
human tissues from their convex hull in the (σ̂, L̂) variable space.
Comprehensive experimental verification of the established approach was per-
formed to investigate its accuracy in a scenario of advanced complexity in either
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composition (animal tissues) or geometric morphology (anthropomorphic phan-
tom). By keeping the other aspect simplified in each case, an SPR reference was
established with an uncertainty of 0.1 % and 0.3 %, respectively. This enabled
sub-percent discrimination of the performance of different methods. In animal
tissues, a mean absolute prediction error of 0.2 % was found for DECT as com-
pared to 1.5 % for SECT. In the main components of the anthropomorphic head
phantom (brain, soft tissue, trabecular bone), the median deviation to the ref-
erence was less than 1 %. In both scenarios, DECT-based SPR prediction thus
demonstrated superior accuracy compared to the standard clinical HLUT-based
method.
A relative comparison in 50 head and prostate tumor patients from a database
of clinical DECT scans revealed significant mean range differences of about 1 mm
(head) and 4 mm (prostate) between the optimized approach and the clinical
standard, thus highlighting clinical relevance. The established method can be
readily implemented either by the CT vendor or in the treatment planning system.
Additional applications of DECT in both photon and ion radiation therapy are
conceivable with a more practical benefit such as the simplification of treatment
planning workflow and reduction of patient dose by performing dose calculation
on contrast-enhanced DECT scans.
In conclusion, a reduction of the uncertainty in SPR prediction to below 1 %
was demonstrated using currently available DECT imaging technology. The ben-
efit in voxelwise SPR prediction most probably translates to an advantage of
similar magnitude in ion ranges. Whether this may ultimately lead to a reduc-
tion of treatment margins remains to be investigated by taking other sources of
range uncertainty into account.
Appendix
A1 — Corrections to the Bethe formula
In its quantum mechanical derivation, the stopping number, L, is expanded in a
perturbation series in z such that
L(β) = L0 + zL1 + z
2L2 . (A.1)
The higher-order Barkas and Bloch terms, zL1 and z
2L2 respectively, are impor-
tant only at low projectile energy. The leading term
L0 =
1
2
ln
(
2mec
2β2Wm
1− β2
)
− β2 − ln I − C/Z − δ/2 (A.2)
depends on the maximum energy transfer to a free electron in one collision, Wm,
and on the mean excitation energy or ‘I-value’, I, of the medium. The shell
correction, −C/Z, becomes relevant at low energy, when the velocity of target
electrons cannot be neglected compared to the projectile velocity. The density
correction, −δ/2, accounts for the polarization of the target medium at high
energy. Both corrections can be neglected in the intermediate energy regime
relevant to ion therapy. For heavy charged particles of mass M with me/M  1
(protons, alphas, ions), Wm, can be written
Wm =
2mec
2β2
1− β2 ·
[
1 + 2
me/M
(1− β2)1/2 + (me/M)
2
]−1
. (A.3)
The factor in square brackets deviates from unity only about 0.1 % (0.01 %) for
proton (carbon ions) at 100 MeV/u. Setting it to unity cancels the dependence
on the projectile mass and simplifies equation A.2, leading to
L ≈ ln
(
2mec
2β2
1− β2
)
− β2 − ln I , (A.4)
which corresponds to equation 2.3.
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Figure 6: Relation between I-value, I, and atomic number, Z.
A2 — Mean excitation energies (I-values)
For pure elements, I-values show a rough correlation with the atomic number,
Z, [64]
I ≈ Z · 10 eV , (A.5)
which applies mainly to higher atomic numbers of about Z > 20 (figure 6).
The data source for elemental I-values used in this thesis is the compilation by
Seltzer & Berger, 1982 [65]. Apart from a list of I-values of pure elements [65,
table 2], they also included recommendations [65, table 6] for adapted elemental
I-values to be used in the calculation of compound I-values via Bragg’s additivity
rule [66].
A3 — The composition of body tissues
Due to the (at least partly) empirical nature of CT-based SPR prediction, cer-
tain knowledge on the elemental composition of tissues is essential. An exhaus-
tive compilation of data available today was performed by Woodard & White,
1986 [48]. For their article entitled ‘The composition of body tissues’, they col-
lected and reprocessed data from several older studies including the compilation
in the ‘Report of the task group on reference man’ by the International Commis-
sion on Radiological Protection (ICRP) from 1975 [67]. The tabulated data in
reference [48] comprises 56 tissues, including the five base constituents of bones:
cortical bone, red marrow, yellow marrow, spongiosa and cartilage. For seven tis-
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sues (e.g., adipose and muscle), the data quality was sufficient to infer the spread
in composition in addition to a single value or population mean.
One year later in 1987, White et al. published ‘average soft-tissue and bone mod-
els for use in radiation dosimetry’ [56], based on volumetric averages of the previ-
ously listed individual tissues according to simple geometrical models of specific
body regions. Concerning the average bones, the provided data are an update
of a previous publication [68], using the more recent values for the bone base
constituents from reference [48].
All mentioned sources refer to healthy adults, apart from a table on the age-
dependent variation of calcium content in cortical bone [48, table IV]. In 1991,
the data on tissue composition was therefore complemented by analyzing various
age groups ‘from fetus to young adult’ [69].
The most current reports from the International Commission on Radiation Units
and Measurements (ICRU) mentioning tissue composition in a given context, for
example, the reports 44, 46 and 73 [70–72], as well as ICRP report 89 [73] mostly
reproduce the tables of the above-described publications by Woodard, White et
al. [48, 56, 69]. To the best knowledge of the author, these tables still represent
the most encompassing compilation. It is therefore recommended to use these
tables directly, rather than the derivatives in the ICRU reports or in Schneider
et al., 2000 [74].
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